Explore ›
Finding
Finding
improvement
Glutamine was well tolerated with only mild side effects in 2% of patients, compliance was 82.5% of prescribed doses, and no significant difference in adverse effects was observed compared to placebo.
| Follow-up | 21 days |
| Comparator | Placebo (L-glycine), identical in texture, aroma, and taste, for 21 days |
| Effect summary | improvement |
| Adverse events | mild side effects 2% |
Connected entities
Interventions
Conditions
Outcomes
Populations
Source
PMC5598352
Glutamine for the treatment of vincristine-induced neuropathy in children and adolescents with cancer